Movement Disorders
Conference Coverage
Management of Lewy body dementia remains complex
ATLANTA – MRI scans can appear “pretty normal” in affected patients.
FDA/CDC
FDA review supports Nuplazid’s safety
From the Journals
Impulse control disorders in Parkinson’s patients may be higher than thought
From the Journals
Monoclonal antibody reduced alpha-synuclein levels in Parkinson’s patients
Evidence-Based Reviews
Repetitive transcranial magnetic stimulation for tic disorders
Evidence is mixed, but rTMS might be an option for patients with treatment-resistant tics.
From the Journals
Anticholinergics’ link to dementia calls for vigilance in elderly
The associations seen were “moderate” but reflect an “appreciable risk” for patients.
Conference Coverage
Real-world data so far support pimavanserin trial results
LOS ANGELES – Two studies report on clinicians’ experiences with 105 patients.
Conference Coverage
VIDEO: Encouraging results reported for novel Huntington’s disease therapy
LOS ANGELES – In a short, 46-patient trial, the antisense oligonucleotide IONIS-HTTRx safely reduced CSF concentrations of the huntingtin protein...
Feature
Psychiatric subspecialty is changing its name
A change to consultation-liaison psychiatry from psychosomatic medicine is seen as good for both patients and doctors.
Daily News Podcast
MDedge Daily News: Could gut bacteria trigger lupus?
And acid suppressors in infancy could fuel allergies later on.
From the Journals
Mutations on LRRK2 gene modify risks for both Crohn’s and Parkinson’s
Allelic variants of the gene had either pathogenic or protective effects.